ZDHHC9 and breast cancer: It has been proved that in breast cancer cell line, overexpressed ZDHHC9 could change RAS protein palmitoylation level and cellular localization, which activated RAS protein and downstream signaling pathways, and eventually result in losing control of cancer cells proliferation, migration and apoptosis.